ClinicalTrials.Veeva

Menu

The Effect of Telephone-Assisted Smoking Cessation Program in Patients Diagnosed With Non-Muscle Invasive Bladder Cancer

B

Bakirkoy Dr. Sadi Konuk Training and Research Hospital

Status

Not yet enrolling

Conditions

Self Efficacy
Non-Muscle Invasive Bladder Cancer
Progression, Disease
Tumor Recurrence
Smoking Behaviors

Treatments

Behavioral: Behavioral: Motivational Interviewing with WhatsApp video call

Study type

Interventional

Funder types

Other

Identifiers

NCT05704231
iremozdemir

Details and patient eligibility

About

This study will be carried out to examine the effect of telephone-assisted smoking cessation program on self-efficacy, smoking behavior, tumor recurrence and progression in patients with non-muscle invasive bladder cancer.

Full description

This study will be conducted to examine the effect of a telephone-assisted smoking cessation program (3 months) on self-efficacy, smoking behavior, tumor recurrence and progression for chronic disease management in patients diagnosed with non-muscle invasive bladder cancer. After 3 months of motivational interviewing was applied to the experimental group, the scales will be applied in the 3rd, 6th and 12th months. The cystoscopy will be performed at 3 and 12 months for tumor recurrence and progression

Enrollment

60 estimated patients

Sex

All

Ages

21+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Being 21 years or older
  • First-time diagnosis of non-muscle invasive bladder cancer (patients with pTa urothelial cancer)
  • Chronic smoking for at least 1 year
  • At least primary school graduate and can speak Turkish
  • Having a smartphone and internet access
  • No communication barrier (speech, vision or hearing problem)
  • Individuals who agree to participate in the research.

Exclusion criteria

  • Patients with positive CIS (carcinoma in situ)
  • Patients with minimal invasion of the lamina propria and above
  • Patients with extravesical extension
  • Patients with synchronous and metachronous tumors
  • Communication disability (speech, vision or hearing problem)

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

60 participants in 2 patient groups

Experimental: Intervention Group
Experimental group
Description:
Motivational Interviewing with WhatsApp video call The individuals in the intervention group will be given a smoking cessation education and motivational interview with a WhatsApp video call for 3 months. The motivational interview will be applied every two weeks, 6 times in total. Self-efficacy scale and smoking behavior scale will be administered again at 3, 6 and 12 months after the intervention. tumor recurrence and progression will be checked by cystoscopy at 3rd and 12th months
Treatment:
Behavioral: Behavioral: Motivational Interviewing with WhatsApp video call
No Intervention: Control Group
No Intervention group
Description:
the control group received the routine care/education provided in the hospital. Self-efficacy scale and smoking behavior scale will be administered again at 3, 6 and 12 months after the routin hospital care. Both intervention and control groups' tumor recurrence and progression will be checked by cystoscopy at the 3rd and 12th months

Trial contacts and locations

1

Loading...

Central trial contact

İREM NUR ÖZDEMİR, PhD, RN.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems